Oncology Institute, Inc. (TOI) Interest & Investment Income (2020 - 2023)

Oncology Institute (TOI) has 3 years of Interest & Investment Income data on file, last reported at $940000.0 in Q3 2023.

• Quarterly Interest & Investment Income changed N/A year-over-year to $940000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $3.2 million (up 54763.75% YoY) and the FY2020 annual result came in at $254149.0, changed N/A from the prior year.
• Interest & Investment Income retreated to $940000.0 in Q3 2023, from $1.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q1 2023 to a low of $5798.0 in Q3 2021.
• A 3-year average of $383437.7 and a median of $73393.0 in 2020 frame the typical range for Interest & Investment Income.
• The widest YoY moves for Interest & Investment Income: up 91.48% in 2021, down 92.1% in 2021.
• Tracing TOI's Interest & Investment Income over 3 years: stood at $59248.0 in 2020, then plunged by 90.21% to $5798.0 in 2021, then soared by 16112.49% to $940000.0 in 2023.
• The last three Interest & Investment Income figures came in at $940000.0 (Q3 2023), $1.0 million (Q2 2023), and $1.2 million (Q1 2023), per Business Quant data.